NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding NeuroPace Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 32 | 28 | −4 |
| Shares | 18.4M | 18.2M | −265.8K (−1.4%) |
| Value | $91.2M | $68.1M | −$23.1M (−25.3%) |
New holders (3)
Institutions that held NeuroPace Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Financial Advocates Investment Management | 10,000 | $38.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,960 | $19.0K | 0.00% |
| UBS Group AG | 2,173 | $8.00K | 0.00% |
Sold out (7)
Institutions that held NeuroPace Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 21,692 | $108.0K |
| Nisa Investment Advisors, LLC | 3,000 | $15.0K |
| Cubist Systematic Strategies, LLC | 651 | $3.00K |
| New York State Common Retirement Fund | 66 | $0 |
| Credit Suisse AG | 4 | $0 |
| Citigroup Inc | 62 | $0 |
| Ellevest, Inc. | 6 | $0 |